IBXNF Stock Price, Chart, Stats & News

Operating internationally, with key markets spanning Canada, the United States, Germany, and the United Kingdom, IBEX Technologies Inc. focuses on the development and sale of enzymes for various biomedical purposes. Its extensive product catalog includes a range of recombinant glycosaminoglycan lyases, such as Heparinase I, II, and III, alongside Chondroitinase AC and B. The company also provides sophisticated research tools, including collagen ELISAs designed to assess the formation and breakdown of connective tissue components, as well as collagen antibodies and a liquid diamine oxidase product.